Global Parkinson’s disease treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024?. Increasing aging population and prevalence of Parkinsonism across the world are main key drivers for Global Parkinson Disease Treatment Market.Report ID: BMRC 62 | Number of pages: 200 | Publish Date: May 2019 | Publisher: BMRC | Category: Chemicals and Materials
Global Parkinson’s disease treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024 Scope of Global Parkinson’s disease treatment Market Reports – Parkinson’s disease is a neuro degenerative disorder in which parts of the brain become progressively damaged over many years. It is a type of movement disorder. It occurs when nerve tissue unable to produce a chemical named ’Dopamine’ which is used to send signals that help you move your body. Parkinson’s disease usually developed for aged people i.e. above 60 years, but it can also start earlier. It is more common in men than in women. The cause of Parkinson’s disease is unknown, but researchers think that both genetic and environmental factors are involved. Primary symptoms include tremors, Stiffness, Slowness, impaired balance, mild memory & Thinking problem and shuffling gait. Secondary symptoms include Anxiety, Depression, Fatigue, Low blood pressure, muscle cramp, Speech & communication problem, skin & Dental Problem and Dizziness, and Dementia. Risk of Parkinson’s disease increases with age and the disease mainly affects person over 50 years of age. The development of Parkinson’s disease and the degree of destruction differ from person to person. Many people with Parkinson’s disease live long productive lives, whereas others become disabled much more quickly. As symptoms worsen, it may become difficult to walk, talk, and complete simple tasks. Malnutrition and weight maintenance is common problem for people with Parkinson’s disease. There is no test to diagnose Parkinson’s disease with certainty. Treatment options include medication or surgical treatment. Combination of Levodopa with carbidopa is considered as a gold standard for symptomatic treatment of Parkinson’s disease. Surgical treatment options include deep brain stimulation and Carbidopa/levodopa enteral suspension therapy but surgical therapy is effective only for patients who have previously responded to Levodopa therapy. Commercially available drugs for treatment of Parkinson’s disease are Sinemet, Safinamide, Rotigotine, Ropinirole, Pramiprexol, Amantidine, Cycloset, Parlodel (Bromocriptine Mesylate), Rytary, Azilect, Northera, Stalevo, Comtess/Comtan and others. More than past decade, huge improvement has been made in the treatment of Parkinson’s disease such as identification of new therapeutic targets through genetic research, understanding the common mutations that contribute to Parkinson’s disease etc. Global Parkinson’s diseases Treatment Market report is segmented on the basis of Medication, Medical devices, End user, Distribution Channels and Geography. Based on Medication Global Parkinson’s disease Treatment Market is classified into Dopamine Precursors, Peripheral Decarboxylase Inhibitors, COMT (Catechol-O-methyltransferase) Inhibitors, MAO (Monoamine Oxidase), Inhibitors and Others (anticholinergics, antihistaminics etc.) On the basis of Medical Devices Global Parkinson’s disease Treatment Market is classified into Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices and others. On the basis of End User Global Parkinson’s disease Treatment Market is classified into Hospitals, Homecare setting, Clinics and Others. On the basis of Distribution Channel Global Parkinson’s disease Drug Market is classified into Retail Pharmacies, Online Pharmacies, Hospital Pharmacies and Drug Stores. The regions covered in Global Parkinson’s diseases Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Parkinson’s disease treatment Market Reports – Global Parkinson’s disease Treatment Market reports cover prominent players like Teva Pharmaceuticals, AstraZeneca, Novartis AG, Boehringer Ingelheim, GlaxoSmithKline Plc., Salix Pharmaceuticals, mpax Laboratories, Orion Corporation, Mylan N.V., Cipla Inc., Daiichi Sankyo, Apotex Inc, Impax Laboratories, Lundbeck, Sun Pharma, Wockhardt ,UCB, Valeant Pharmaceuticals Acadia, Abbvie, Zydus Cadilla, Strides, 1 A Pharma, Upsher-Smith, Intas, US World Meds, Dr. Reddy’s, Medtronic plc, Biotie Therapies Corp., Adamas Pharmaceuticals Inc., Akorn Inc., Astellas Pharma Inc., Desitin Arzneimittel GmbH, Endo International plc, Kyowa Hakko Kirin, Newron Pharmaceuticals and Merck. Global Parkinson’s disease treatment Market Dynamics – Global Parkinson’s disease Treatment Market is mainly driven by growing prevalence of Parkinson’s disease and government funding for research on Parkinson’s disease. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are few other causes which are possible to boost the Parkinson’s disease Treatment market. However some restraints like availability of alternative treatments is expected to hold back market and expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the termination of Parkinson’s disease Treatment market. High cost of treatment such as 14.4 Billion USD and lack of expertise for early diagnosis is likely to restrict the market growth. Also lack of novel and successful therapies in the market to reduce the risk of mortality restraints for this market. The opportunities for Global Parkinson’s disease Treatment market includes upcoming technologies like surface EMG (Electromyography) sensors, Pulse oximetry sensors, development in personalized medicine along with huge investment in anti-Parkinson’s drugs research will boost the global Parkinson’s disease Treatment market. Also development of novel drugs and combination therapy with less side effects and better survival rates is expected to increase the global Parkinson’s disease Treatment market. Global Parkinson’s disease treatment Market Regional Analysis – Europe is likely to achieve the largest share of the global Parkinson’s disease treatment market, which is expected to be followed by North America with a sizeable market share. High knowledge about the treatment, increase in expenditure for Research & Development, favorable medicinal reimbursement regulations and policies, the high occurrence of Parkinson’s disease, the rapidly growing geriatric population and potential medical pipeline products are likely to contribute to the major share of Europe in Global Parkinson’s disease treatment market. The global Parkinson’s disease treatment market in the Asia Pacific is anticipated to develop at a profitable rate. The market share of the global Parkinson’s disease treatment market is to be expected to grasp by China and Japan in the Asia Pacific, due to the large population of elderly people who are affected with Parkinson’s disease. Furthermore, increase in awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent. Key Benefits for Global Parkinson’s disease treatment Market Reports – Global Parkinson’s disease Treatment Market report covers in depth historical and forecast analysis. Global Parkinson’s disease Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level. Global Parkinson’s disease Treatment Market report helps to identify opportunities in market place. Global Parkinson’s disease Treatment Market report covers extensive analysis of emerging trends and competitive landscape. Global Parkinson’s disease treatment Market Segmentation – Global Parkinson’s disease Treatment Market: By Medication Analysis Dopamine Precursor Peripheral Decarboxylase Inhibitors COMT (Catechol-O-methyltransferase) Inhibitors MAO(monoamine oxidase) Inhibitors Others (anticholinergics, antihistaminics etc.) Global Parkinson’s disease Treatment Market: By Medical Devices Analysis Deep Brain Stimulation (DBS) Devices Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices Others Global Parkinson’s disease Treatment Market: By End User Analysis Hospitals Clinics Homecare setting Others Global Parkinson’s disease Treatment Market: By Distribution Channel Retail Pharmacies Online Pharmacies Hospital Pharmacies Drug Store Global Parkinson’s disease Treatment Market: By Regional & Country Analysis North America U.S. Mexico Canada Europe UK France Germany Italy Asia Pacific China Japan India Southeast Asia Latin America Brazil The Middle East and Africa GCC Africa Rest of Middle East and Africa
Interested in this report?
Get your sample now!
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.